Sign up for 30 days of no-obligation access for all the essential news during this critical time -- you'll be able to choose one of our online services as part of your trial: Inside CMS, FDA Week, Health Exchange Alert, Inside Drug Pricing or Inside TeleHealth.


Top Stories

Reconciliation Bill Eliminates Cost-Sharing For Adult Vaccinations

The senate’s reconciliation package may not include the mandatory one-year continuous coverage for Medicaid- and CHIP-enrolled children and postpartum women that beneficiary advocates were hoping for, but it includes a requirement, originally part of the Build Back Better plan, that would expand adult access to vaccinations by eliminating Medicaid cost sharing, as well as making vaccines available at no cost to adult Medicare and Children’s Health Insurance Program beneficiaries.

Stakeholders Celebrate Senate’s Vote to Extend ACA Subsidies

Senate Dems Pass Historic Medicare Drug Negotiation Plan, Enhanced ACA Credit Extension

Comprehensive Abortion Coverage

GOP Hones Abortion Language; IN Enacts Strict Ban; MN Court Hears Emergency Contraception Case

Clashes over emergency contraception are emerging in state courts, a reality abortion advocates feared would flare in the wake of the June 24 Dobbs v. Jackson Women’s Health Organization decision, as GOP talking points on abortion policy begin to circulate.

Dems Push HHS, DOJ To Strengthen Protections For Medication Abortion

WH: Abortion PHE, PREP Act Would Do Little To Protect Women, Providers

More Coverage →

Latest Pandemic News

HHS Reports On Long COVID Disappoint Patient Advocates

Advocates for long COVID patients are upset two major reports on the Biden administration’s plans to research the condition and support those with the condition didn’t go farther, saying the reports fail to offer adequate assistance and funding for patients.

Wastewater Sampling, ‘Nowcasting’ Emerge As COVID Decision Tools

HHS Lays Out ‘Long COVID’ Research Plan; Patient, Provider Support

More Coverage →

Latest News

Providers are asking for lawmakers’ help in heading off Medicare pay cuts going into 2023 as congressional staff discussions on a year-end package reportedly kick off.

Federal agencies signed numerous contracts with private entities that granted those entities broad authorization to use protected intellectual property without asking for permission from rights holders, Knowledge Economy International found in a what it called an “eye-opening” review of contracts with companies involved in the COVID-19 pandemic response.

The American Hospital Association and 62 other health care organizations are urging the House and Senate Judiciary committees to pass a bipartisan bill before the end of the 117th Congress that would raise the cap on the number of foreign providers who can work in the United States, a solution the sector eyes with increasing enthusiasm as the heath care workforce crisis rages on.

HHS awarded $60 million to stabilize the health care workforce in rural areas across the country in a bid to improve quality of care and retain providers as rampant shortages continue to strain the health care sector.

Gain-of-function research, which is used to better understand which pathogens have the potential to become a pandemic, should be subject to additional government oversight since it could accidentally or deliberately be misused, experts from academia and the biopharmaceutical industry told members of the Senate Homeland Security committee’s emerging threats subcommittee Wednesday (Aug. 3).

Senate Republicans garnered enough votes Sunday (Aug. 7) to axe Democrats’ bid to apply a $35 insulin out-of-pocket cap to private plans in addition to Medicare, after Democrats essentially dared Republicans to make the politically unpopular move by rebuffing an earlier parliamentarian ruling and including private insulin caps in the bill they took to the Senate floor.

The Senate Parliamentarian has given the green light to Democrats’ long-sought plan for Medicare to negotiate drug prices, but she axed reconciliation language that would have required drug companies pay Medicare back when they raise prices for drugs sold in the private market faster than inflation.